We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$18.7B
AUM Growth
+$1.89B
(+11%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 2 |
Norwegian Cruise Line
NCLH
|
+$105M |
| 3 |
Goldman Sachs
GS
|
+$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$101M |
| 5 |
Steel Dynamics
STLD
|
+$99.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$176M |
| 2 |
Coca-Cola
KO
|
+$151M |
| 3 |
Broadcom
AVGO
|
+$146M |
| 4 |
Microsoft
MSFT
|
+$140M |
| 5 |
ExxonMobil
XOM
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Industrials | 11.65% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 11.56% |
| 5 | Financials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Equinor
EQNR
$95.9B
| $25.8M | 0.14% |
720,079
+4,934
| +0.7% | +$177K |
|
202
Lockheed Martin
LMT
$134B
| $25.7M | 0.14% |
52,870
-34,560
| -40% | -$16.1M |
|
203
Zillow
Z
$7.04B
| $25.7M | 0.14% |
798,449
+783,926
| +5,398% | +$26M |
|
204
Polaris
PII
$4.15B
| $25.5M | 0.14% |
252,139
+244,058
| +3,020% | +$25.4M |
|
205
Ralph Lauren
RL
$22.2B
| $25.5M | 0.14% |
+240,895
| New | +$24.1M |
|
206
Costco
COST
$415B
| $25.4M | 0.14% |
55,738
-127,038
| -70% | -$62.1M |
|
|
BLD
207
DELISTED
TopBuild
BLD
| $25.4M | 0.14% |
162,306
+76,035
| +88% | +$12.1M |
|
208
Reinsurance Group of America
RGA
$15.7B
| $25.4M | 0.14% |
178,576
+124,754
| +232% | +$17.4M |
|
209
EPAM Systems
EPAM
$4.69B
| $25.3M | 0.14% |
+77,312
| New | +$26.3M |
|
210
Raymond James Financial
RJF
$32.5B
| $25.2M | 0.14% |
236,253
+168,068
| +246% | +$18.9M |
|
211
Lear
LEA
$7.19B
| $25.2M | 0.13% |
+203,063
| New | +$26.9M |
|
212
Advanced Drainage Systems
WMS
$10.9B
| $25.2M | 0.13% |
307,128
+63,003
| +26% | +$6.38M |
|
|
STOR
213
DELISTED
STORE Capital Corporation
STOR
| $25M | 0.13% |
+779,497
| New | +$24.7M |
|
214
CDW
CDW
$17.1B
| $25M | 0.13% |
139,896
+24,002
| +21% | +$4.22M |
|
215
Owens Corning
OC
$11.5B
| $24.8M | 0.13% |
291,246
+264,194
| +977% | +$23.2M |
|
216
Caesars Entertainment
CZR
$6.1B
| $24.8M | 0.13% |
594,972
+161,144
| +37% | +$7.18M |
|
217
Service Corp International
SCI
$11.4B
| $24.7M | 0.13% |
357,832
+116,831
| +48% | +$7.78M |
|
|
AXON
218
Axon Enterprise
AXON
$40.5B
| $24.7M | 0.13% |
+149,102
| New | +$23.6M |
|
219
Copart
CPRT
$25.9B
| $24.7M | 0.13% |
811,294
-214,482
| -21% | -$6.42M |
|
220
Align Technology
ALGN
$12B
| $24.6M | 0.13% |
116,615
+36,394
| +45% | +$7.28M |
|
221
Paylocity
PCTY
$6.71B
| $24.5M | 0.13% |
126,357
+90,122
| +249% | +$19.4M |
|
222
BHP
BHP
$213B
| $24.5M | 0.13% |
394,847
+115,880
| +42% | +$6.52M |
|
223
CALL
Philip Morris
PM
$301B
| $24.3M | 0.13% |
+240,000
| New | +$22.6M |
|
|
224
PUT
Philip Morris
PM
$301B
| $24.3M | 0.13% |
+240,000
| New | +$22.6M |
|
225
Live Nation Entertainment
LYV
$41.2B
| $24.3M | 0.13% |
347,939
+26,297
| +8% | +$1.95M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review
As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.
- Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
- Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
- Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
- Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
- Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.